SI1673391T1 - Modificirana cDNA za visoke ekspresijske nivoje faktorja VIII in njegovih derivatov - Google Patents

Modificirana cDNA za visoke ekspresijske nivoje faktorja VIII in njegovih derivatov

Info

Publication number
SI1673391T1
SI1673391T1 SI200431057T SI200431057T SI1673391T1 SI 1673391 T1 SI1673391 T1 SI 1673391T1 SI 200431057 T SI200431057 T SI 200431057T SI 200431057 T SI200431057 T SI 200431057T SI 1673391 T1 SI1673391 T1 SI 1673391T1
Authority
SI
Slovenia
Prior art keywords
derivatives
factor viii
dna sequences
expression vectors
expression levels
Prior art date
Application number
SI200431057T
Other languages
English (en)
Inventor
Hans-Peter Hauser
Jean-Luc Plantier
Cecille Ducasse
Claude Negrier
Original Assignee
Claude Negrier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Claude Negrier filed Critical Claude Negrier
Publication of SI1673391T1 publication Critical patent/SI1673391T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SI200431057T 2003-10-16 2004-10-13 Modificirana cDNA za visoke ekspresijske nivoje faktorja VIII in njegovih derivatov SI1673391T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03023637 2003-10-16
PCT/EP2004/011445 WO2005040213A1 (en) 2003-10-16 2004-10-13 MODIFIED cDNA FOR HIGH EXPRESSION LEVELS OF FACTOR VIII AND ITS DERIVATIVES
EP04790326A EP1673391B1 (en) 2003-10-16 2004-10-13 MODIFIED cDNA FOR HIGH EXPRESSION LEVELS OF FACTOR VIII AND ITS DERIVATIVES

Publications (1)

Publication Number Publication Date
SI1673391T1 true SI1673391T1 (sl) 2009-06-30

Family

ID=34486073

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200431057T SI1673391T1 (sl) 2003-10-16 2004-10-13 Modificirana cDNA za visoke ekspresijske nivoje faktorja VIII in njegovih derivatov

Country Status (15)

Country Link
US (1) US20080312143A1 (sl)
EP (1) EP1673391B1 (sl)
JP (1) JP4804356B2 (sl)
AT (1) ATE417066T1 (sl)
AU (1) AU2004283833A1 (sl)
BR (1) BRPI0415296A (sl)
CA (1) CA2541280A1 (sl)
DE (1) DE602004018349D1 (sl)
DK (1) DK1673391T3 (sl)
ES (1) ES2319198T3 (sl)
IL (1) IL174645A0 (sl)
PL (1) PL1673391T3 (sl)
PT (1) PT1673391E (sl)
SI (1) SI1673391T1 (sl)
WO (1) WO2005040213A1 (sl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4870208B2 (ja) * 2006-05-17 2012-02-08 エフ．ホフマン−ラ ロシュ アーゲー ポリペプチド産生細胞
FR2913020B1 (fr) 2007-02-23 2012-11-23 Biomethodes Nouveaux facteurs viii pour le traitement des hemophiles de type a
WO2017180857A1 (en) 2016-04-15 2017-10-19 The Trustees Of The University Of Pennsylvania Gene therapy for treating hemophilia a
WO2018060239A1 (en) 2016-09-29 2018-04-05 F. Hoffmann-La Roche Ag Improved method for selecting polypeptide producing cells
CN109507435A (zh) * 2018-11-23 2019-03-22 重庆医科大学 Grp78蛋白双抗夹心elisa法检测试剂盒及其检测方法
GB202108855D0 (en) * 2021-06-21 2021-08-04 Cambridge Entpr Ltd Methods of eukaryotic gene expression

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2197321B (en) * 1986-09-12 1990-10-03 Genentech Inc Method and vectors for obtaining continuous production of heterologous protein in a eukaryotic host cell line
EP0629700A3 (en) * 1993-06-10 1995-02-15 Miles Inc Vector and mammalian cell line having improved productivity.
EP1038959A1 (en) * 1999-03-17 2000-09-27 Aventis Behring Gesellschaft mit beschränkter Haftung Factor VIII without B-domain, comprising one or more insertions of a truncated intron I of factor IX
EP1048726B1 (en) * 1999-04-27 2006-07-26 Négrier, Claude Modified factor VIII cDNA
EP1233064A1 (en) * 2001-02-09 2002-08-21 Aventis Behring Gesellschaft mit beschränkter Haftung Modified factor VIII cDNA and its use for the production of factor VIII
EP1284290A1 (en) * 2001-08-08 2003-02-19 Aventis Behring GmbH Increase of the expression levels of factor VIII by insertion of spliceable nucleotide sequences into factor VIII cDNA
EP1283263A1 (en) * 2001-08-08 2003-02-12 Aventis Behring GmbH Modified cDNA for high expression levels of factor VIII and its derivatives

Also Published As

Publication number Publication date
AU2004283833A1 (en) 2005-05-06
BRPI0415296A (pt) 2006-12-26
ES2319198T3 (es) 2009-05-05
JP2007537713A (ja) 2007-12-27
PT1673391E (pt) 2009-03-18
EP1673391B1 (en) 2008-12-10
EP1673391A1 (en) 2006-06-28
JP4804356B2 (ja) 2011-11-02
CA2541280A1 (en) 2005-05-06
DK1673391T3 (da) 2009-04-06
US20080312143A1 (en) 2008-12-18
IL174645A0 (en) 2006-08-20
ATE417066T1 (de) 2008-12-15
DE602004018349D1 (de) 2009-01-22
WO2005040213A1 (en) 2005-05-06
PL1673391T3 (pl) 2009-06-30

Similar Documents

Publication Publication Date Title
PL1781782T3 (pl) Zmodyfikowane polipeptydy zależne od witaminy K
WO2006128668A3 (en) Coagulation factor x polypeptides with modified activation properties
MXPA03010079A (es) Formulaciones de oxicodona de administracion una vez al dia.
HK1125659A1 (en) Kdr peptides and vaccines comprising the same kdr
ATE301201T1 (de) Für die gentherapie verwendbare plasmide
IL174645A0 (en) MODIFIED cDNA FOR HIGH EXPRESSION LEVELS OF FACTOR VIII AND ITS DERIVATIVES
NZ505063A (en) Pharmaceutical use of long pentraxin PTX3 in treating tumour conditions
SI1675956T1 (sl) Minimalno zaporedje dna, ki deluje kot izolirni element kromatina in njegova uporaba pri ekspresiji proteinov
ZA200108414B (en) Akt nucleic acids, polypeptides, and uses thereof.
NZ334839A (en) Polynucleotide molecules encoding neospora proteins and uses thereof
WO2002102316A3 (en) Histone deacetylase and methods of use thereof
TW200716749A (en) Interferon-beta gene therapy using an improved, regulated expression system
EP1221487A3 (en) Polynucleotide molecules encoding neospora proteins
WO2003095612A3 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2002050255A3 (en) Isolated human dehydrogenases, nucleic acid molecules encoding them, and uses thereof
WO2001092301A3 (en) Placc, a novel human c-c chemokine isolated from placenta
AU2003296543A8 (en) Peptides having a high cysteine content
MY134618A (en) Filarial parasite polypeptides and sequences, gene sequences and uses thereof
WO2003097793A3 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2002074973A9 (en) Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
WO2003076577A3 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2003076576A3 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2003093435A3 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof